Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_assertion evidence source_evidence_literature NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_assertion SIO_000772 20587546 NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_assertion wasDerivedFrom gad-20150221 NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_assertion wasGeneratedBy ECO_0000203 NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.
- gad-20150221 importedOn "2015-02-21" NP130375.RA6_vpY7FrnK1R5Lh_IQ2r92u77pB9qR50Bc1DPXP9H6M130_provenance.